- Home
- PTY vs VCYT Comparison
PTY vs VCYT Comparison
Compare PTY & VCYT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | PTY | VCYT |
|---|---|---|
| Founded | N/A | 2006 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Investment Managers | Medical Specialities |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.5B | 3.1B |
| IPO Year | 2002 | 2013 |
Fundamental Metrics
Financial Performance| Metric | PTY | VCYT |
|---|---|---|
| Price | $11.87 | $46.96 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 7 |
| Target Price | N/A | ★ $44.00 |
| AVG Volume (30 Days) | ★ 1.0M | 1.0M |
| Earning Date | 01-01-0001 | 05-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 164.52 |
| EPS | N/A | ★ 0.35 |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | $13.76 |
| Revenue Next Year | N/A | $12.35 |
| P/E Ratio | ★ N/A | $136.11 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $11.58 | $22.61 |
| 52 Week High | $14.69 | $50.71 |
Technical Indicators
Market Signals| Indicator | PTY | VCYT |
|---|---|---|
| Relative Strength Index (RSI) | 43.42 | 71.36 |
| Support Level | $11.65 | $41.03 |
| Resistance Level | $13.17 | $50.71 |
| Average True Range (ATR) | 0.10 | 2.04 |
| MACD | -0.01 | 0.54 |
| Stochastic Oscillator | 42.86 | 86.20 |
Price Performance
Historical ComparisonAbout PTY Pimco Corporate & Income Opportunity Fund
PIMCO Corporate & Income Opportunity Fds operates as a closed-end management investment company. It seeks to maximize total return through a combination of current income and capital appreciation. The fund invests a majority of the total assets in a combination of corporate debt obligations of varying maturities, other corporate income-producing securities, and income-producing securities of non-corporate issuers, such as U.S. Government securities, municipal securities, and mortgage-backed and other asset-backed securities issued on a public or private basis.
About VCYT Veracyte Inc.
Veracyte Inc is a genomic diagnostics company. The group empowers clinicians with the insights necessary to guide and assure patients at pivotal moments in the race to diagnose and treat cancer. It offers tests for prostate cancer (Decipher Prostate), thyroid cancer (Afirma), breast cancer (Prosigna), and bladder cancer (Decipher Bladder).